CeriBell

Update in progress

CBLL (NasdaqGS)

Company RatingNeutral
SectorHealthcare
IndustryMedical Devices

CeriBell, Inc. is a U.S. medical technology company developing the Ceribell System, a point‑of‑care EEG platform for acute care patients. It offers disposable headbands and headcaps, a pocket‑sized rechargeable recorder for wireless EEG transmission, and Clarity, an AI seizure detection algorithm. The firm also operates an EEG portal for real-time remote data access. Formerly Brain Stethoscope, Inc., renamed in 2015; founded in 2014 and based in Sunnyvale, California.

Company score

Sentiment: 0.54; SentimentMeasures the overall tone of recent coverage and discussion about the company.−10 negative · 0 neutral · +10 positive
Environment: 0.00; EnvironmentAssesses the company’s environmental impact, risks, and sustainability practices.−10 negative · 0 neutral · +10 positive
Social: 0.49; SocialAssesses the company’s influence on employees, customers, communities, and wider society.−10 negative · 0 neutral · +10 positive
Governance: 0.10; GovernanceAssesses leadership, accountability, transparency, and business ethics.−10 negative · 0 neutral · +10 positive
Sustainability: 0.17; SustainabilityCombines environmental, social, and governance signals into an overall sustainability score.−10 negative · 0 neutral · +10 positive
Impact Score: 0.35; Impact ScoreCombines sentiment and sustainability performance into an assessment of the company’s overall impact.−10 negative · 0 neutral · +10 positive